Does architectural lighting contribute to breast cancer?

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Figueiro, Mariana G ^a   Rea, Mark S ^a   Bullough, John D ^a  

^a RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CIRCADIAN RHYTHM; FEMALE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; ILLUMINATION; LIGHT EXPOSURE; NIGHT WORK; NONHUMAN; PHOTOMETRY; REVIEW; TUMOR GROWTH;

EID: 33748691855     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-20     Document Type: Review

References (76)

1. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, Edwards BK: Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996, 88:1571-1579.
2. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M: Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003, 53:342-355.
3. Cohen M, Lippman M, Chabner B: Role of pineal gland in the aetiology and treatment of breast cancer. Lancet 1978, 2:814-816.
4. Stevens RG: Electric power use and breast cancer a hypothesis. Am J Epidemiol 1987, 125:556-561.
5. Commission International de I'Éclairage (CIE): Light As a True Visual Quantity: Principles of Measurement No. 41 Paris: Commission Internationale de I'Éclairage; 1978.
6. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS: New insights into melatonin regulation of cancer growth. Adv Exp Med Biol 1999, 460:337-343.
7. Blask DE, Dauchy RT, Sauer LA. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 2005, 27:179-188.
8. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T: Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 1996, 7:197-204.
9. Hansen J: Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 2001, 93:1513-1515.
10. Davis S, Mirick DK, Stevens RG: Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001, 93:1557-1562.
11. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA: Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 2001, 93:1563-1568.
12. Stevens RG: Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005, 16:254-258.
13. Hrushesky WJ: Tumor chronobiology. J Control Release 2001, 74:27-30.
14. Hrushesky WJ: Circadian timing of cancer chemotherapy. Science 1985, 228:73-75.
15. Rea MS, Figueiro MG, Bullough JD: Circadian photobiology: an emerging framework for lighting practice and research. Lighting Res Technol 2002, 34:177-190.
16. Arendt J: Melatonin and the Mammalian Pineal Gland 1st edition, London: Chapman & Hall; 1995.
17. Carrillo-vico A, Guerrero JM, Lardone PJ, Reiter RJ: A review of the multiple actions of melatonin on the immune system. Endocrine 2005, 27:189-200.
18. Erren TC, Reiter RJ, Piekarski C: Light, timing of biological rhythms, and chronodisruption in man. Naturwissenschaften 2003, 90:485-494.
19. Chen LJ, Gao YQ, Li XJ, Shen DH, Sun FY: Melatonin protects against MPTP/ MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 2005, 39:34-42.
20. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, Lynch DT, Rollag MD, Zalatan F: Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res 2005, 65:11174-11184.
21. Reiter RJ: Mechanisms of cancer inhibition by melatonin. J Pineal Res 2004, 37:213-214.
22. Belanger CF, Hennekens CH, Rosner B, Speizer FE: The Nurses' Health Study. Am J Nurs 1978, 78:1039-40.
23. Feychting M, Osterlund B, Ahlbom A: Reduced cancer incidence among the blind. Epidemiology 1998, 9:490-4.
24. Lockley SW, Skene DJ, Arendt J, Tabandeh H, Bird AC, Defrance R: Relationship between melatonin rhythms and visual loss in the blind. J Clin Endocrinol Metab 1997, 82:3763-3770.
25. Pauley SM: Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. Med Hypotheses 2004, 63:588-596.
26. Rea MS, Ed: IESNA Lighting Handbook: Reference and Application 9th edition. New York. Illuminating Engineering Society of North America; 2000.
27. Ramanath J: Retinal flux density measurements and conventional illuminance measurements: a field comparison. In MS thesis Rensselaer Polytechnic Institute, Lighting; 2003.
28. Bierman A, Klein TR, Rea MS: The Daysimeter: a device for measuring optical radiation as a stimulus for the human circadian system. Meas Sci Technol 2005, 16:2292-2299.
29. Hebert M, Martin SK, Lee C, Eastman CI: The effects of prior light history on the suppression of melatonin by light in humans. J Pineal Res 2002, 33:198-203.
30. Smith KA, Schoen MW, Czeisler CA: Adaptation of human pineal melatonin suppression by recent photic history. J Clin Endocrinol Metab 2004, 89:3610-3614.
31. Lynch HJ, Deng MH, Wurtman RJ: Indirect effects of light: ecological and ethological considerations. Ann N Y Acad Sci 1985, 453:231-241.
32. Bullough JD, Figueiro MG, Rea MS: Of mice and women: light as a circadian stimulus in breast cancer research. Cancer Causes Control 2006, 17:375-383.
33. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA: Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett 1999, 144:131-136.
34. Bullough JD, Figueiro MG, Possidente BP, Parsons RH, Rea MS: Additivity in murine circadian phototransduction. Zoolog Sci 2005, 22:223-227.
35. Figueiro, MG, Bullough JD, Parsons RH, Rea MS: Preliminary evidence for spectral opponency in the suppression of melatonin by light in humans. Neuroreport 2004, 15:313-316.
36. Figueiro MG, Bullough JD, Bierman A, Rea MS: Demonstration of additivity failure in human circadian phototransduction. Neuroendocrinol Lett 2005, 26:493-498.
37. Rea MS, Figueiro MG, Bullough JD, Bierman A: A model of phototransduction by the human circadian system. Brain Res Rev 2005, 50:213-28.
38. Dacey DM, Liao HW, Peterson BB, Robinson FR, Smith VC, Pokorny J, Yau KW, Gamlin PD: Melanopsin-expressing ganglion cells in primate retina signal colour and irradiance and project to the LGN. Nature 2005, 433:749-754.
39. DiBerardinis LJ, Baum JS, First MW, Gatwood GT, Groden E, Seth AK: Guidelines for Laboratory Design: Health and Safety Considerations 2nd edition. New York, Wiley-Interscience; 1993.
40. DiBerardinis LJ, Baum JS, First MW, Gatwood GT, Seth AK: Guidelines for Laboratory Design: Health and Safety Considerations 3rd edition. New York Wiley-interscience; 2001.
41. Mcintyre IM, Norman TR, Burrows GD, Armstrong SM: Human melatonin suppression by light is intensity dependent. J Pineal Res 1989, 6:149-156.
42. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD: Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci 2001, 21:6405-6412.
43. Thapan K, Arendt J, Skene DJ: An action spectrum for melatonin suppression: evidence for a novel non-rod, non-cone photoreceptor system in humans. J Physiol 2001, 535:261-267.
44. Rea MS, Bullough JD, Figueiro MG: Human melatonin suppression by light: a case for scotopic efficiency. Neurosci Lett 2001, 299:45-48.
45. Rea MS, Bullough JD, Figueiro MG: Phototransduction for human melatonin suppression. J Pineal Res 2002, 32:209-213.
46. Commission International de I'Éclairage (CIE): Colorimetry, No. 15 Vienna: Commission Internationale de I'Éclairage; 2004.
47. Zeitzer JM, Khalsa SB, Boivin DB, Duffy JF, Shanahan TL, Kronauer RE, Czeisler CA: Temporal dynamics of late-night photic stimulation of the human circadian timing system. Am J Physiol 2005, 289:R839-R844.
48. Charman WN: Age, lens transmittance, and the possible effects of light on melatonin suppression. Ophthalmic Physiol Opt 2003, 23:181-187.
49. Jean-Louis G, Kripke DF, Elliott JA, Zizi F, Wolintz AH, Lazzaro DR: Daily illumination exposure and melatonin: influence of ophthalmic dysfunction and sleep duration. J Circadian Rhythms 2005, 3:13.
50. Burgess HJ, Eastman CI: Early versus late bedtimes phase shifts the human dim light melatonin rhythm despite a fixed morning lights on time. Neurosci Lett 2004, 356:115-118.
51. Burgess HJ, Eastman CI: A late wake time phase delays the human dim light melatonin rhythm. Neurosci Lett 2006, 395:191-195.
52. Aeschbach D, Sher L, Postolache T, Matthews J, Jackson M, Wehr T: A longer biological night in long sleepers than in short sleepers. J Clin Endocrinol Metab 2003, 88:26-30.
53. Wehr T: In short photoperiods, human sleep is biphasic. Sleep Res 1991, 1:103-107.
54. Boyce PR: Movement under emergency lighting: the effect of illuminance. Lighting Res Technol 1985, 17:51-71.
55. Ouellette MJ, Rea MS: Illuminance requirements for emergency lighting. J Illum Eng Soc 1989, 18:37-42.
56. Leslie RP: A simple cost estimation technique for improving the appearance and security of outdoor lighting installations. Building Env 1998, 33:79-95.
57. Loomis D, Marshall SW, Wolf SH, Runyan CW, Butts JD: Effectiveness of safety measures recommended for prevention of workplace homicide. J Am Med Assoc 2002, 287:1011-1017.
58. Figueiro, MG: Lighting the Way: A Key to Independence Troy: Rensselaer Polytechnic Institute; 2001.
59. Bergeron E, Clement J, Lavoie A, Ratte S, Bamvita JM, Aumont F, Clas D: A simple fall in the elderly: Not so simple. J Trauma 2006, 60:268-273.
60. Figueiro MG, Rea MS: LEDs: Improving the sleep quality of older adults. Proceedings of the CIE Midterm Meeting and International Lighting Congress: 18-21 May 2005; Leon.
61. Robinson J, Bayliss SC, Fielder AR. Transmission of light across the adult and neonatal eyelid in vivo. Vision Res 1991, 31:1837-1840.
62. Jean-Louis G, Kripke DF, Cole RJ, Elliot JA: No melatonin suppression by illumination of popliteall fossae or eyelids. J Biol Rhythms 2000, 15:265-269.
63. Hatonen T, Alila-Johansson A, Mustanoja S, Laakso ML: Suppression of melatonin by 2000-lux light in humans with closed eyelids. Biol Psychiatry 1999, 46:827-831.
64. Knight JA, Thompson S, Raboud JM, Hoffman BR: Light and exercise and melatonin production in women. Am J Epidemiol 2005, 162:1114-1122.
65. Borugian MJ, Gallagher RP, Friesen MC, Switzer TF, Aronson KJ: Twenty-four-hour light exposure and melatonin levels among shift workers. J Occup Environ Med 2005, 47:1268-1275.
66. Bullough J, Rea MS, Stevens RG: Light and magnetic fields in a neonatal intensive care unit. Bioelectromagnetics 1996, 17:396-405.
67. Waterhouse J, Buckley P, Edwards B, Reilly T: Measurement of, and some reasons for, differences in eating habits between night and day workers. chronobiol Int 2003, 20:1075-1092.
68. Wright KP, Myers BL, Plenzler SC, Drake CL, Badia P: Acute effects of bright light and caffeine on nighttime melatonin and temperature levels in women taking and not taking oral contraceptives. Brain Res 2000, 873:310-317.
69. Van Cauter E, Plat L, Leproult R, Copinschi G: Alterations of circadian rhythmicity and sleep in aging: endocrine consequences. Horm Res 1998, 49:147-52.
70. Bryant PA, Trinder J, Curtis N: Sick and tired: does sleep have a vital role in the immune system? Nat Rev Immunol 2004, 4:457-467.
71. Kojo K, Pukkala E, Auvinen A: Breast cancer risk among Finnish cabin attendants: a nested case-control study. Occup Environ Med 2005, 62:488-493.
72. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE: Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. J Pineal Res 2006, 40:116-124.
73. Cos S, Sanchez-Barcelo EJ: Melatonin and mammary pathological growth. Front Neuroendocrinol 2000, 21:133-170.
74. Van Der Pompe G, Antoni MH, Heijnen CJ: Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996, 21:361-374.
75. Zheng W, Jin F, Dunning LA, Shu XO, Dai Q, Wen VVQ, Gao YT, Holtzman JL. Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol Biomorkers Prev 2001, 10:237-242.
76. Schernhammer ES, Kroenke CH, Laden F, Hankinson SE: Night work and risk of breast cancer. Epidemiology 2006, 17:108-111.